Apigenin Attenuates Allergic Responses of Ovalbumin-Induced Allergic Rhinitis Through Modulation of Th1/Th2 Responses in Experimental Mice
Overview
Authors
Affiliations
Background: Allergic rhinitis (AR) is an immunoglobulin E (IgE)-mediated immune-inflammatory response mainly affecting nasal mucosa. Apigenin, a flavonoid, has been documented to possess promising anti-allergic potential.
Aim: To determine the potential mechanism of action of apigenin against ovalbumin (OVA)-induced AR by assessing various behavioral, biochemical, molecular, and ultrastructural modifications.
Materials And Methods: Allergic rhinitis was induced in BALB/c mice (18-22 grams) by sensitizing it with OVA (5%, 500 μL, intraperitoneal [IP] on each consecutive day, for 13 days) followed by intranasal challenge with OVA (5%, 5 μL per nostril on day 21). Animals were treated with either vehicle (distilled water, 10 mg/kg, IP) or apigenin (5, 10, and 20 mg/kg, IP).
Results: Intranasal challenge of OVA resulted in significant induction ( < .05) of AR reflected by an increase in nasal symptoms (sneezing, rubbing, and discharge), which were ameliorated significantly ( < .05) by apigenin (10 and 20 mg/kg) treatment. It also significantly inhibited ( < .05) OVA-induced elevated serum histamine, OVA-specific IgE, total IgE, and IgG1 and β-hexosaminidase levels. Ovalbumin-induced increased levels of interleukin (IL)-4, IL-5, IL-13, and interferon (IFN)-γ in nasal lavage fluid were significantly decreased ( < .05) by apigenin. Ovalbumin-induced alterations in splenic GATA binding protein 3 (ie, erythroid transcription factor) (GATA3), T-box protein expressed in T cells (T-bet), signal transducer and activator of transcription-6 (STAT6), suppressor of cytokine signaling 1 (SOCS1), nuclear factor-kappa B (NF-κB), and nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-alpha messenger RNA, as well as protein expressions were significantly inhibited ( < .05) by apigenin. It also significantly ameliorated ( < .05) nasal and spleen histopathologic and ultrastructure aberration induced by OVA.
Conclusion: Apigenin regulates Th1/Th2 balance via suppression in expressions of Th2 response (IgE, histamine, ILs, GATA3, STAT6, SOCS1, and NF-κB) and activation of Th1 response (IFN-γ and T-bet) to exert its anti-allergic potential in a murine model of OVA-induced AR.
Zhang M, Sun X, Yu X, Xu L, Zhang X, Zhang R Front Microbiol. 2025; 16:1522191.
PMID: 40066267 PMC: 11891226. DOI: 10.3389/fmicb.2025.1522191.
Moradi S, Khazaei H, Tarlan M, Jasemi S, Joshi T, Aneva I Front Pharmacol. 2024; 15:1447097.
PMID: 39403140 PMC: 11472003. DOI: 10.3389/fphar.2024.1447097.
Liu Y, Liu S, Meng L, Fang L, Yu J, Yue J Inflamm Res. 2024; 73(10):1819-1832.
PMID: 39180692 PMC: 11445352. DOI: 10.1007/s00011-024-01933-1.
Li Y, An R, Wu M, He J, He X Anal Cell Pathol (Amst). 2024; 2024:5531970.
PMID: 38455868 PMC: 10919974. DOI: 10.1155/2024/5531970.
Yu W, Du J, Peng L, Zhang T Immun Inflamm Dis. 2023; 11(10):e1017.
PMID: 37904695 PMC: 10580702. DOI: 10.1002/iid3.1017.